img

Global Intrathecal Drug Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Intrathecal Drug Market Insights, Forecast to 2034

Intrathecal administration is a route of administration for drugs via an injection into the spinal canal, or into the subarachnoid space so that it reaches the cerebrospinal fluid (CSF) and is useful in spinal anaesthesia, chemotherapy, or pain management applications. This route is also used to introduce drugs that fight certain infections, particularly post-neurosurgical. The drug needs to be given this way to avoid being stopped by the blood brain barrier. The same drug given orally must enter the blood stream and may not be able to pass out and into the brain. Drugs given by the intrathecal route often have to be compounded specially by a pharmacist or technician because they cannot contain any preservative or other potentially harmful inactive ingredients that are sometimes found in standard injectable drug preparations.
Global Intrathecal Drug market is expected to reach to US$ 631 million in 2024, with a positive growth of %, compared with US$ 604 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Intrathecal Drug industry is evaluated to reach US$ 885 million in 2029. The CAGR will be 5.8% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Intrathecal Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Intrathecal Drug market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Medtronic
Jazz Pharmaceuticals
West Ward Pharmaceutical
Saol Therapeutics
Piramal Critical Care
Fresenius Kabi
Segment by Type
Baclofen Injection
Ziconotide Intrathecal Infusion
Morphine Injection

Segment by Application


Adult
Child & Teen

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Intrathecal Drug plant distribution, commercial date of Intrathecal Drug, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Intrathecal Drug introduction, etc. Intrathecal Drug Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Intrathecal Drug
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Intrathecal Drug Product Introduction
1.2 Market by Type
1.2.1 Global Intrathecal Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Baclofen Injection
1.2.3 Ziconotide Intrathecal Infusion
1.2.4 Morphine Injection
1.3 Market by Application
1.3.1 Global Intrathecal Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Adult
1.3.3 Child & Teen
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Intrathecal Drug Sales Estimates and Forecasts 2018-2029
2.2 Global Intrathecal Drug Revenue by Region
2.2.1 Global Intrathecal Drug Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Intrathecal Drug Revenue by Region (2018-2024)
2.2.3 Global Intrathecal Drug Revenue by Region (2024-2029)
2.2.4 Global Intrathecal Drug Revenue Market Share by Region (2018-2029)
2.3 Global Intrathecal Drug Sales Estimates and Forecasts 2018-2029
2.4 Global Intrathecal Drug Sales by Region
2.4.1 Global Intrathecal Drug Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Intrathecal Drug Sales by Region (2018-2024)
2.4.3 Global Intrathecal Drug Sales by Region (2024-2029)
2.4.4 Global Intrathecal Drug Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Intrathecal Drug Sales by Manufacturers
3.1.1 Global Intrathecal Drug Sales by Manufacturers (2018-2024)
3.1.2 Global Intrathecal Drug Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Intrathecal Drug in 2022
3.2 Global Intrathecal Drug Revenue by Manufacturers
3.2.1 Global Intrathecal Drug Revenue by Manufacturers (2018-2024)
3.2.2 Global Intrathecal Drug Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Intrathecal Drug Revenue in 2022
3.3 Global Key Players of Intrathecal Drug, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Intrathecal Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Intrathecal Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Intrathecal Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Intrathecal Drug, Product Offered and Application
3.8 Global Key Manufacturers of Intrathecal Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Intrathecal Drug Sales by Type
4.1.1 Global Intrathecal Drug Historical Sales by Type (2018-2024)
4.1.2 Global Intrathecal Drug Forecasted Sales by Type (2024-2029)
4.1.3 Global Intrathecal Drug Sales Market Share by Type (2018-2029)
4.2 Global Intrathecal Drug Revenue by Type
4.2.1 Global Intrathecal Drug Historical Revenue by Type (2018-2024)
4.2.2 Global Intrathecal Drug Forecasted Revenue by Type (2024-2029)
4.2.3 Global Intrathecal Drug Revenue Market Share by Type (2018-2029)
4.3 Global Intrathecal Drug Price by Type
4.3.1 Global Intrathecal Drug Price by Type (2018-2024)
4.3.2 Global Intrathecal Drug Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Intrathecal Drug Sales by Application
5.1.1 Global Intrathecal Drug Historical Sales by Application (2018-2024)
5.1.2 Global Intrathecal Drug Forecasted Sales by Application (2024-2029)
5.1.3 Global Intrathecal Drug Sales Market Share by Application (2018-2029)
5.2 Global Intrathecal Drug Revenue by Application
5.2.1 Global Intrathecal Drug Historical Revenue by Application (2018-2024)
5.2.2 Global Intrathecal Drug Forecasted Revenue by Application (2024-2029)
5.2.3 Global Intrathecal Drug Revenue Market Share by Application (2018-2029)
5.3 Global Intrathecal Drug Price by Application
5.3.1 Global Intrathecal Drug Price by Application (2018-2024)
5.3.2 Global Intrathecal Drug Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Intrathecal Drug Market Size by Type
6.1.1 US & Canada Intrathecal Drug Sales by Type (2018-2029)
6.1.2 US & Canada Intrathecal Drug Revenue by Type (2018-2029)
6.2 US & Canada Intrathecal Drug Market Size by Application
6.2.1 US & Canada Intrathecal Drug Sales by Application (2018-2029)
6.2.2 US & Canada Intrathecal Drug Revenue by Application (2018-2029)
6.3 US & Canada Intrathecal Drug Market Size by Country
6.3.1 US & Canada Intrathecal Drug Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Intrathecal Drug Sales by Country (2018-2029)
6.3.3 US & Canada Intrathecal Drug Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Intrathecal Drug Market Size by Type
7.1.1 Europe Intrathecal Drug Sales by Type (2018-2029)
7.1.2 Europe Intrathecal Drug Revenue by Type (2018-2029)
7.2 Europe Intrathecal Drug Market Size by Application
7.2.1 Europe Intrathecal Drug Sales by Application (2018-2029)
7.2.2 Europe Intrathecal Drug Revenue by Application (2018-2029)
7.3 Europe Intrathecal Drug Market Size by Country
7.3.1 Europe Intrathecal Drug Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Intrathecal Drug Sales by Country (2018-2029)
7.3.3 Europe Intrathecal Drug Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Intrathecal Drug Market Size
8.1.1 China Intrathecal Drug Sales (2018-2029)
8.1.2 China Intrathecal Drug Revenue (2018-2029)
8.2 China Intrathecal Drug Market Size by Application
8.2.1 China Intrathecal Drug Sales by Application (2018-2029)
8.2.2 China Intrathecal Drug Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Intrathecal Drug Market Size by Type
9.1.1 Asia Intrathecal Drug Sales by Type (2018-2029)
9.1.2 Asia Intrathecal Drug Revenue by Type (2018-2029)
9.2 Asia Intrathecal Drug Market Size by Application
9.2.1 Asia Intrathecal Drug Sales by Application (2018-2029)
9.2.2 Asia Intrathecal Drug Revenue by Application (2018-2029)
9.3 Asia Intrathecal Drug Sales by Region
9.3.1 Asia Intrathecal Drug Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Intrathecal Drug Revenue by Region (2018-2029)
9.3.3 Asia Intrathecal Drug Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Intrathecal Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Intrathecal Drug Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Intrathecal Drug Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Intrathecal Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Intrathecal Drug Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Intrathecal Drug Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Intrathecal Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Intrathecal Drug Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Intrathecal Drug Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Intrathecal Drug Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Medtronic
11.1.1 Medtronic Company Information
11.1.2 Medtronic Overview
11.1.3 Medtronic Intrathecal Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Medtronic Intrathecal Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Medtronic Recent Developments
11.2 Jazz Pharmaceuticals
11.2.1 Jazz Pharmaceuticals Company Information
11.2.2 Jazz Pharmaceuticals Overview
11.2.3 Jazz Pharmaceuticals Intrathecal Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Jazz Pharmaceuticals Intrathecal Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Jazz Pharmaceuticals Recent Developments
11.3 West Ward Pharmaceutical
11.3.1 West Ward Pharmaceutical Company Information
11.3.2 West Ward Pharmaceutical Overview
11.3.3 West Ward Pharmaceutical Intrathecal Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 West Ward Pharmaceutical Intrathecal Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 West Ward Pharmaceutical Recent Developments
11.4 Saol Therapeutics
11.4.1 Saol Therapeutics Company Information
11.4.2 Saol Therapeutics Overview
11.4.3 Saol Therapeutics Intrathecal Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Saol Therapeutics Intrathecal Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Saol Therapeutics Recent Developments
11.5 Piramal Critical Care
11.5.1 Piramal Critical Care Company Information
11.5.2 Piramal Critical Care Overview
11.5.3 Piramal Critical Care Intrathecal Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Piramal Critical Care Intrathecal Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Piramal Critical Care Recent Developments
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Information
11.6.2 Fresenius Kabi Overview
11.6.3 Fresenius Kabi Intrathecal Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Fresenius Kabi Intrathecal Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Fresenius Kabi Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Intrathecal Drug Industry Chain Analysis
12.2 Intrathecal Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Intrathecal Drug Production Mode & Process
12.4 Intrathecal Drug Sales and Marketing
12.4.1 Intrathecal Drug Sales Channels
12.4.2 Intrathecal Drug Distributors
12.5 Intrathecal Drug Customers
13 Market Dynamics
13.1 Intrathecal Drug Industry Trends
13.2 Intrathecal Drug Market Drivers
13.3 Intrathecal Drug Market Challenges
13.4 Intrathecal Drug Market Restraints
14 Key Findings in The Global Intrathecal Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Intrathecal Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Baclofen Injection
Table 3. Major Manufacturers of Ziconotide Intrathecal Infusion
Table 4. Major Manufacturers of Morphine Injection
Table 5. Global Intrathecal Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Intrathecal Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Intrathecal Drug Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Intrathecal Drug Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Intrathecal Drug Revenue Market Share by Region (2018-2024)
Table 10. Global Intrathecal Drug Revenue Market Share by Region (2024-2029)
Table 11. Global Intrathecal Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Intrathecal Drug Sales by Region (2018-2024) & (K Units)
Table 13. Global Intrathecal Drug Sales by Region (2024-2029) & (K Units)
Table 14. Global Intrathecal Drug Sales Market Share by Region (2018-2024)
Table 15. Global Intrathecal Drug Sales Market Share by Region (2024-2029)
Table 16. Global Intrathecal Drug Sales by Manufacturers (2018-2024) & (K Units)
Table 17. Global Intrathecal Drug Sales Share by Manufacturers (2018-2024)
Table 18. Global Intrathecal Drug Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Intrathecal Drug Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Intrathecal Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Intrathecal Drug Price by Manufacturers 2018-2024 (USD/Unit)
Table 22. Global Intrathecal Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Intrathecal Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intrathecal Drug as of 2022)
Table 24. Global Key Manufacturers of Intrathecal Drug, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Intrathecal Drug, Product Offered and Application
Table 26. Global Key Manufacturers of Intrathecal Drug, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Intrathecal Drug Sales by Type (2018-2024) & (K Units)
Table 29. Global Intrathecal Drug Sales by Type (2024-2029) & (K Units)
Table 30. Global Intrathecal Drug Sales Share by Type (2018-2024)
Table 31. Global Intrathecal Drug Sales Share by Type (2024-2029)
Table 32. Global Intrathecal Drug Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Intrathecal Drug Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Intrathecal Drug Revenue Share by Type (2018-2024)
Table 35. Global Intrathecal Drug Revenue Share by Type (2024-2029)
Table 36. Intrathecal Drug Price by Type (2018-2024) & (USD/Unit)
Table 37. Global Intrathecal Drug Price Forecast by Type (2024-2029) & (USD/Unit)
Table 38. Global Intrathecal Drug Sales by Application (2018-2024) & (K Units)
Table 39. Global Intrathecal Drug Sales by Application (2024-2029) & (K Units)
Table 40. Global Intrathecal Drug Sales Share by Application (2018-2024)
Table 41. Global Intrathecal Drug Sales Share by Application (2024-2029)
Table 42. Global Intrathecal Drug Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Intrathecal Drug Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Intrathecal Drug Revenue Share by Application (2018-2024)
Table 45. Global Intrathecal Drug Revenue Share by Application (2024-2029)
Table 46. Intrathecal Drug Price by Application (2018-2024) & (USD/Unit)
Table 47. Global Intrathecal Drug Price Forecast by Application (2024-2029) & (USD/Unit)
Table 48. US & Canada Intrathecal Drug Sales by Type (2018-2024) & (K Units)
Table 49. US & Canada Intrathecal Drug Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada Intrathecal Drug Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Intrathecal Drug Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Intrathecal Drug Sales by Application (2018-2024) & (K Units)
Table 53. US & Canada Intrathecal Drug Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada Intrathecal Drug Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Intrathecal Drug Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Intrathecal Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Intrathecal Drug Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Intrathecal Drug Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Intrathecal Drug Sales by Country (2018-2024) & (K Units)
Table 60. US & Canada Intrathecal Drug Sales by Country (2024-2029) & (K Units)
Table 61. Europe Intrathecal Drug Sales by Type (2018-2024) & (K Units)
Table 62. Europe Intrathecal Drug Sales by Type (2024-2029) & (K Units)
Table 63. Europe Intrathecal Drug Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Intrathecal Drug Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Intrathecal Drug Sales by Application (2018-2024) & (K Units)
Table 66. Europe Intrathecal Drug Sales by Application (2024-2029) & (K Units)
Table 67. Europe Intrathecal Drug Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Intrathecal Drug Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Intrathecal Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Intrathecal Drug Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Intrathecal Drug Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Intrathecal Drug Sales by Country (2018-2024) & (K Units)
Table 73. Europe Intrathecal Drug Sales by Country (2024-2029) & (K Units)
Table 74. China Intrathecal Drug Sales by Type (2018-2024) & (K Units)
Table 75. China Intrathecal Drug Sales by Type (2024-2029) & (K Units)
Table 76. China Intrathecal Drug Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Intrathecal Drug Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Intrathecal Drug Sales by Application (2018-2024) & (K Units)
Table 79. China Intrathecal Drug Sales by Application (2024-2029) & (K Units)
Table 80. China Intrathecal Drug Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Intrathecal Drug Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Intrathecal Drug Sales by Type (2018-2024) & (K Units)
Table 83. Asia Intrathecal Drug Sales by Type (2024-2029) & (K Units)
Table 84. Asia Intrathecal Drug Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Intrathecal Drug Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Intrathecal Drug Sales by Application (2018-2024) & (K Units)
Table 87. Asia Intrathecal Drug Sales by Application (2024-2029) & (K Units)
Table 88. Asia Intrathecal Drug Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Intrathecal Drug Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Intrathecal Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Intrathecal Drug Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Intrathecal Drug Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Intrathecal Drug Sales by Region (2018-2024) & (K Units)
Table 94. Asia Intrathecal Drug Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America Intrathecal Drug Sales by Type (2018-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Intrathecal Drug Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Intrathecal Drug Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Intrathecal Drug Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Intrathecal Drug Sales by Application (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Intrathecal Drug Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Intrathecal Drug Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Intrathecal Drug Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Intrathecal Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Intrathecal Drug Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Intrathecal Drug Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Intrathecal Drug Sales by Country (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Intrathecal Drug Sales by Country (2024-2029) & (K Units)
Table 108. Medtronic Company Information
Table 109. Medtronic Description and Major Businesses
Table 110. Medtronic Intrathecal Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. Medtronic Intrathecal Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Medtronic Recent Developments
Table 113. Jazz Pharmaceuticals Company Information
Table 114. Jazz Pharmaceuticals Description and Major Businesses
Table 115. Jazz Pharmaceuticals Intrathecal Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. Jazz Pharmaceuticals Intrathecal Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Jazz Pharmaceuticals Recent Developments
Table 118. West Ward Pharmaceutical Company Information
Table 119. West Ward Pharmaceutical Description and Major Businesses
Table 120. West Ward Pharmaceutical Intrathecal Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. West Ward Pharmaceutical Intrathecal Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. West Ward Pharmaceutical Recent Developments
Table 123. Saol Therapeutics Company Information
Table 124. Saol Therapeutics Description and Major Businesses
Table 125. Saol Therapeutics Intrathecal Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Saol Therapeutics Intrathecal Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Saol Therapeutics Recent Developments
Table 128. Piramal Critical Care Company Information
Table 129. Piramal Critical Care Description and Major Businesses
Table 130. Piramal Critical Care Intrathecal Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. Piramal Critical Care Intrathecal Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Piramal Critical Care Recent Developments
Table 133. Fresenius Kabi Company Information
Table 134. Fresenius Kabi Description and Major Businesses
Table 135. Fresenius Kabi Intrathecal Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Fresenius Kabi Intrathecal Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Fresenius Kabi Recent Developments
Table 138. Key Raw Materials Lists
Table 139. Raw Materials Key Suppliers Lists
Table 140. Intrathecal Drug Distributors List
Table 141. Intrathecal Drug Customers List
Table 142. Intrathecal Drug Market Trends
Table 143. Intrathecal Drug Market Drivers
Table 144. Intrathecal Drug Market Challenges
Table 145. Intrathecal Drug Market Restraints
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Intrathecal Drug Product Picture
Figure 2. Global Intrathecal Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Intrathecal Drug Market Share by Type in 2022 & 2029
Figure 4. Baclofen Injection Product Picture
Figure 5. Ziconotide Intrathecal Infusion Product Picture
Figure 6. Morphine Injection Product Picture
Figure 7. Global Intrathecal Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Intrathecal Drug Market Share by Application in 2022 & 2029
Figure 9. Adult
Figure 10. Child & Teen
Figure 11. Intrathecal Drug Report Years Considered
Figure 12. Global Intrathecal Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Intrathecal Drug Revenue 2018-2029 (US$ Million)
Figure 14. Global Intrathecal Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Intrathecal Drug Revenue Market Share by Region (2018-2029)
Figure 16. Global Intrathecal Drug Sales 2018-2029 ((K Units)
Figure 17. Global Intrathecal Drug Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Intrathecal Drug Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Intrathecal Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Intrathecal Drug Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Intrathecal Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Intrathecal Drug Sales YoY (2018-2029) & (K Units)
Figure 23. China Intrathecal Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Intrathecal Drug Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Intrathecal Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Intrathecal Drug Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Intrathecal Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Intrathecal Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Intrathecal Drug in the World: Market Share by Intrathecal Drug Revenue in 2022
Figure 30. Global Intrathecal Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Intrathecal Drug Sales Market Share by Type (2018-2029)
Figure 32. Global Intrathecal Drug Revenue Market Share by Type (2018-2029)
Figure 33. Global Intrathecal Drug Sales Market Share by Application (2018-2029)
Figure 34. Global Intrathecal Drug Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Intrathecal Drug Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Intrathecal Drug Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Intrathecal Drug Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Intrathecal Drug Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Intrathecal Drug Revenue Share by Country (2018-2029)
Figure 40. US & Canada Intrathecal Drug Sales Share by Country (2018-2029)
Figure 41. U.S. Intrathecal Drug Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Intrathecal Drug Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Intrathecal Drug Sales Market Share by Type (2018-2029)
Figure 44. Europe Intrathecal Drug Revenue Market Share by Type (2018-2029)
Figure 45. Europe Intrathecal Drug Sales Market Share by Application (2018-2029)
Figure 46. Europe Intrathecal Drug Revenue Market Share by Application (2018-2029)
Figure 47. Europe Intrathecal Drug Revenue Share by Country (2018-2029)
Figure 48. Europe Intrathecal Drug Sales Share by Country (2018-2029)
Figure 49. Germany Intrathecal Drug Revenue (2018-2029) & (US$ Million)
Figure 50. France Intrathecal Drug Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Intrathecal Drug Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Intrathecal Drug Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Intrathecal Drug Revenue (2018-2029) & (US$ Million)
Figure 54. China Intrathecal Drug Sales Market Share by Type (2018-2029)
Figure 55. China Intrathecal Drug Revenue Market Share by Type (2018-2029)
Figure 56. China Intrathecal Drug Sales Market Share by Application (2018-2029)
Figure 57. China Intrathecal Drug Revenue Market Share by Application (2018-2029)
Figure 58. Asia Intrathecal Drug Sales Market Share by Type (2018-2029)
Figure 59. Asia Intrathecal Drug Revenue Market Share by Type (2018-2029)
Figure 60. Asia Intrathecal Drug Sales Market Share by Application (2018-2029)
Figure 61. Asia Intrathecal Drug Revenue Market Share by Application (2018-2029)
Figure 62. Asia Intrathecal Drug Revenue Share by Region (2018-2029)
Figure 63. Asia Intrathecal Drug Sales Share by Region (2018-2029)
Figure 64. Japan Intrathecal Drug Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Intrathecal Drug Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Intrathecal Drug Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Intrathecal Drug Revenue (2018-2029) & (US$ Million)
Figure 68. India Intrathecal Drug Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Intrathecal Drug Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Intrathecal Drug Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Intrathecal Drug Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Intrathecal Drug Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Intrathecal Drug Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Intrathecal Drug Sales Share by Country (2018-2029)
Figure 75. Brazil Intrathecal Drug Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Intrathecal Drug Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Intrathecal Drug Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Intrathecal Drug Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Intrathecal Drug Revenue (2018-2029) & (US$ Million)
Figure 80. Intrathecal Drug Value Chain
Figure 81. Intrathecal Drug Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed